FCGR1 Antibody Market - Global Outlook and Forecast 2022-2028

January 2022 | 74 pages | ID: FEB9C49F6C69EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of FCGR1 Antibody in Global, including the following market information:

Global FCGR1 Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global FCGR1 Antibody market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Above 95% Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of FCGR1 Antibody include Bio-Rad, Lifespan Biosciences, R&D Systems, Thermo Fisher Scientific, Novus Biologicals, Genetex, Biobyt, Aviva Systems Biology and ProSci, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the FCGR1 Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global FCGR1 Antibody Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global FCGR1 Antibody Market Segment Percentages, by Type, 2021 (%)

• Above 95%
• Above 99%
• Others

Global FCGR1 Antibody Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global FCGR1 Antibody Market Segment Percentages, by Application, 2021 (%)

• Biopharmaceutical Companies
• Hospitals
• Bioscience Research Institutions
• Others

Global FCGR1 Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global FCGR1 Antibody Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies FCGR1 Antibody revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies FCGR1 Antibody revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bio-Rad
• Lifespan Biosciences
• R&D Systems
• Thermo Fisher Scientific
• Novus Biologicals
• Genetex
• Biobyt
• Aviva Systems Biology
• ProSci
• BioLegend
• Boster Bio
• Abbexa Ltd

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 FCGR1 Antibody Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global FCGR1 Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL FCGR1 ANTIBODY OVERALL MARKET SIZE

2.1 Global FCGR1 Antibody Market Size: 2021 VS 2028
2.2 Global FCGR1 Antibody Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top FCGR1 Antibody Players in Global Market
3.2 Top Global FCGR1 Antibody Companies Ranked by Revenue
3.3 Global FCGR1 Antibody Revenue by Companies
3.4 Top 3 and Top 5 FCGR1 Antibody Companies in Global Market, by Revenue in 2021
3.5 Global Companies FCGR1 Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 FCGR1 Antibody Players in Global Market
  3.6.1 List of Global Tier 1 FCGR1 Antibody Companies
  3.6.2 List of Global Tier 2 and Tier 3 FCGR1 Antibody Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global FCGR1 Antibody Market Size Markets, 2021 & 2028
  4.1.2 Above 95%
  4.1.3 Above 99%
  4.1.4 Others
4.2 By Type - Global FCGR1 Antibody Revenue & Forecasts
  4.2.1 By Type - Global FCGR1 Antibody Revenue, 2017-2022
  4.2.2 By Type - Global FCGR1 Antibody Revenue, 2023-2028
  4.2.3 By Type - Global FCGR1 Antibody Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global FCGR1 Antibody Market Size, 2021 & 2028
  5.1.2 Biopharmaceutical Companies
  5.1.3 Hospitals
  5.1.4 Bioscience Research Institutions
  5.1.5 Others
5.2 By Application - Global FCGR1 Antibody Revenue & Forecasts
  5.2.1 By Application - Global FCGR1 Antibody Revenue, 2017-2022
  5.2.2 By Application - Global FCGR1 Antibody Revenue, 2023-2028
  5.2.3 By Application - Global FCGR1 Antibody Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global FCGR1 Antibody Market Size, 2021 & 2028
6.2 By Region - Global FCGR1 Antibody Revenue & Forecasts
  6.2.1 By Region - Global FCGR1 Antibody Revenue, 2017-2022
  6.2.2 By Region - Global FCGR1 Antibody Revenue, 2023-2028
  6.2.3 By Region - Global FCGR1 Antibody Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America FCGR1 Antibody Revenue, 2017-2028
  6.3.2 US FCGR1 Antibody Market Size, 2017-2028
  6.3.3 Canada FCGR1 Antibody Market Size, 2017-2028
  6.3.4 Mexico FCGR1 Antibody Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe FCGR1 Antibody Revenue, 2017-2028
  6.4.2 Germany FCGR1 Antibody Market Size, 2017-2028
  6.4.3 France FCGR1 Antibody Market Size, 2017-2028
  6.4.4 U.K. FCGR1 Antibody Market Size, 2017-2028
  6.4.5 Italy FCGR1 Antibody Market Size, 2017-2028
  6.4.6 Russia FCGR1 Antibody Market Size, 2017-2028
  6.4.7 Nordic Countries FCGR1 Antibody Market Size, 2017-2028
  6.4.8 Benelux FCGR1 Antibody Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia FCGR1 Antibody Revenue, 2017-2028
  6.5.2 China FCGR1 Antibody Market Size, 2017-2028
  6.5.3 Japan FCGR1 Antibody Market Size, 2017-2028
  6.5.4 South Korea FCGR1 Antibody Market Size, 2017-2028
  6.5.5 Southeast Asia FCGR1 Antibody Market Size, 2017-2028
  6.5.6 India FCGR1 Antibody Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America FCGR1 Antibody Revenue, 2017-2028
  6.6.2 Brazil FCGR1 Antibody Market Size, 2017-2028
  6.6.3 Argentina FCGR1 Antibody Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa FCGR1 Antibody Revenue, 2017-2028
  6.7.2 Turkey FCGR1 Antibody Market Size, 2017-2028
  6.7.3 Israel FCGR1 Antibody Market Size, 2017-2028
  6.7.4 Saudi Arabia FCGR1 Antibody Market Size, 2017-2028
  6.7.5 UAE FCGR1 Antibody Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bio-Rad
  7.1.1 Bio-Rad Corporate Summary
  7.1.2 Bio-Rad Business Overview
  7.1.3 Bio-Rad FCGR1 Antibody Major Product Offerings
  7.1.4 Bio-Rad FCGR1 Antibody Revenue in Global Market (2017-2022)
  7.1.5 Bio-Rad Key News
7.2 Lifespan Biosciences
  7.2.1 Lifespan Biosciences Corporate Summary
  7.2.2 Lifespan Biosciences Business Overview
  7.2.3 Lifespan Biosciences FCGR1 Antibody Major Product Offerings
  7.2.4 Lifespan Biosciences FCGR1 Antibody Revenue in Global Market (2017-2022)
  7.2.5 Lifespan Biosciences Key News
7.3 R&D Systems
  7.3.1 R&D Systems Corporate Summary
  7.3.2 R&D Systems Business Overview
  7.3.3 R&D Systems FCGR1 Antibody Major Product Offerings
  7.3.4 R&D Systems FCGR1 Antibody Revenue in Global Market (2017-2022)
  7.3.5 R&D Systems Key News
7.4 Thermo Fisher Scientific
  7.4.1 Thermo Fisher Scientific Corporate Summary
  7.4.2 Thermo Fisher Scientific Business Overview
  7.4.3 Thermo Fisher Scientific FCGR1 Antibody Major Product Offerings
  7.4.4 Thermo Fisher Scientific FCGR1 Antibody Revenue in Global Market (2017-2022)
  7.4.5 Thermo Fisher Scientific Key News
7.5 Novus Biologicals
  7.5.1 Novus Biologicals Corporate Summary
  7.5.2 Novus Biologicals Business Overview
  7.5.3 Novus Biologicals FCGR1 Antibody Major Product Offerings
  7.5.4 Novus Biologicals FCGR1 Antibody Revenue in Global Market (2017-2022)
  7.5.5 Novus Biologicals Key News
7.6 Genetex
  7.6.1 Genetex Corporate Summary
  7.6.2 Genetex Business Overview
  7.6.3 Genetex FCGR1 Antibody Major Product Offerings
  7.6.4 Genetex FCGR1 Antibody Revenue in Global Market (2017-2022)
  7.6.5 Genetex Key News
7.7 Biobyt
  7.7.1 Biobyt Corporate Summary
  7.7.2 Biobyt Business Overview
  7.7.3 Biobyt FCGR1 Antibody Major Product Offerings
  7.7.4 Biobyt FCGR1 Antibody Revenue in Global Market (2017-2022)
  7.7.5 Biobyt Key News
7.8 Aviva Systems Biology
  7.8.1 Aviva Systems Biology Corporate Summary
  7.8.2 Aviva Systems Biology Business Overview
  7.8.3 Aviva Systems Biology FCGR1 Antibody Major Product Offerings
  7.8.4 Aviva Systems Biology FCGR1 Antibody Revenue in Global Market (2017-2022)
  7.8.5 Aviva Systems Biology Key News
7.9 ProSci
  7.9.1 ProSci Corporate Summary
  7.9.2 ProSci Business Overview
  7.9.3 ProSci FCGR1 Antibody Major Product Offerings
  7.9.4 ProSci FCGR1 Antibody Revenue in Global Market (2017-2022)
  7.9.5 ProSci Key News
7.10 BioLegend
  7.10.1 BioLegend Corporate Summary
  7.10.2 BioLegend Business Overview
  7.10.3 BioLegend FCGR1 Antibody Major Product Offerings
  7.10.4 BioLegend FCGR1 Antibody Revenue in Global Market (2017-2022)
  7.10.5 BioLegend Key News
7.11 Boster Bio
  7.11.1 Boster Bio Corporate Summary
  7.11.2 Boster Bio Business Overview
  7.11.3 Boster Bio FCGR1 Antibody Major Product Offerings
  7.11.4 Boster Bio FCGR1 Antibody Revenue in Global Market (2017-2022)
  7.11.5 Boster Bio Key News
7.12 Abbexa Ltd
  7.12.1 Abbexa Ltd Corporate Summary
  7.12.2 Abbexa Ltd Business Overview
  7.12.3 Abbexa Ltd FCGR1 Antibody Major Product Offerings
  7.12.4 Abbexa Ltd FCGR1 Antibody Revenue in Global Market (2017-2022)
  7.12.5 Abbexa Ltd Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. FCGR1 Antibody Market Opportunities & Trends in Global Market
Table 2. FCGR1 Antibody Market Drivers in Global Market
Table 3. FCGR1 Antibody Market Restraints in Global Market
Table 4. Key Players of FCGR1 Antibody in Global Market
Table 5. Top FCGR1 Antibody Players in Global Market, Ranking by Revenue (2021)
Table 6. Global FCGR1 Antibody Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global FCGR1 Antibody Revenue Share by Companies, 2017-2022
Table 8. Global Companies FCGR1 Antibody Product Type
Table 9. List of Global Tier 1 FCGR1 Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 FCGR1 Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global FCGR1 Antibody Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - FCGR1 Antibody Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - FCGR1 Antibody Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global FCGR1 Antibody Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - FCGR1 Antibody Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - FCGR1 Antibody Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global FCGR1 Antibody Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global FCGR1 Antibody Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global FCGR1 Antibody Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America FCGR1 Antibody Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America FCGR1 Antibody Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe FCGR1 Antibody Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe FCGR1 Antibody Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia FCGR1 Antibody Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia FCGR1 Antibody Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America FCGR1 Antibody Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America FCGR1 Antibody Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa FCGR1 Antibody Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa FCGR1 Antibody Revenue, (US$, Mn), 2023-2028
Table 30. Bio-Rad Corporate Summary
Table 31. Bio-Rad FCGR1 Antibody Product Offerings
Table 32. Bio-Rad FCGR1 Antibody Revenue (US$, Mn), (2017-2022)
Table 33. Lifespan Biosciences Corporate Summary
Table 34. Lifespan Biosciences FCGR1 Antibody Product Offerings
Table 35. Lifespan Biosciences FCGR1 Antibody Revenue (US$, Mn), (2017-2022)
Table 36. R&D Systems Corporate Summary
Table 37. R&D Systems FCGR1 Antibody Product Offerings
Table 38. R&D Systems FCGR1 Antibody Revenue (US$, Mn), (2017-2022)
Table 39. Thermo Fisher Scientific Corporate Summary
Table 40. Thermo Fisher Scientific FCGR1 Antibody Product Offerings
Table 41. Thermo Fisher Scientific FCGR1 Antibody Revenue (US$, Mn), (2017-2022)
Table 42. Novus Biologicals Corporate Summary
Table 43. Novus Biologicals FCGR1 Antibody Product Offerings
Table 44. Novus Biologicals FCGR1 Antibody Revenue (US$, Mn), (2017-2022)
Table 45. Genetex Corporate Summary
Table 46. Genetex FCGR1 Antibody Product Offerings
Table 47. Genetex FCGR1 Antibody Revenue (US$, Mn), (2017-2022)
Table 48. Biobyt Corporate Summary
Table 49. Biobyt FCGR1 Antibody Product Offerings
Table 50. Biobyt FCGR1 Antibody Revenue (US$, Mn), (2017-2022)
Table 51. Aviva Systems Biology Corporate Summary
Table 52. Aviva Systems Biology FCGR1 Antibody Product Offerings
Table 53. Aviva Systems Biology FCGR1 Antibody Revenue (US$, Mn), (2017-2022)
Table 54. ProSci Corporate Summary
Table 55. ProSci FCGR1 Antibody Product Offerings
Table 56. ProSci FCGR1 Antibody Revenue (US$, Mn), (2017-2022)
Table 57. BioLegend Corporate Summary
Table 58. BioLegend FCGR1 Antibody Product Offerings
Table 59. BioLegend FCGR1 Antibody Revenue (US$, Mn), (2017-2022)
Table 60. Boster Bio Corporate Summary
Table 61. Boster Bio FCGR1 Antibody Product Offerings
Table 62. Boster Bio FCGR1 Antibody Revenue (US$, Mn), (2017-2022)
Table 63. Abbexa Ltd Corporate Summary
Table 64. Abbexa Ltd FCGR1 Antibody Product Offerings
Table 65. Abbexa Ltd FCGR1 Antibody Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. FCGR1 Antibody Segment by Type in 2021
Figure 2. FCGR1 Antibody Segment by Application in 2021
Figure 3. Global FCGR1 Antibody Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global FCGR1 Antibody Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global FCGR1 Antibody Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by FCGR1 Antibody Revenue in 2021
Figure 8. By Type - Global FCGR1 Antibody Revenue Market Share, 2017-2028
Figure 9. By Application - Global FCGR1 Antibody Revenue Market Share, 2017-2028
Figure 10. By Region - Global FCGR1 Antibody Revenue Market Share, 2017-2028
Figure 11. By Country - North America FCGR1 Antibody Revenue Market Share, 2017-2028
Figure 12. US FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 13. Canada FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe FCGR1 Antibody Revenue Market Share, 2017-2028
Figure 16. Germany FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 17. France FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 19. Italy FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 20. Russia FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia FCGR1 Antibody Revenue Market Share, 2017-2028
Figure 24. China FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 25. Japan FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 28. India FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America FCGR1 Antibody Revenue Market Share, 2017-2028
Figure 30. Brazil FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa FCGR1 Antibody Revenue Market Share, 2017-2028
Figure 33. Turkey FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 34. Israel FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 36. UAE FCGR1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 37. Bio-Rad FCGR1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Lifespan Biosciences FCGR1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. R&D Systems FCGR1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Thermo Fisher Scientific FCGR1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novus Biologicals FCGR1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Genetex FCGR1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Biobyt FCGR1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Aviva Systems Biology FCGR1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. ProSci FCGR1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. BioLegend FCGR1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Boster Bio FCGR1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Abbexa Ltd FCGR1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)